Financial News
BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)
All News about BioMarin Pharmaceutical Inc. - Common Stock

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAM, INNV and BMRN
November 09, 2021
From The Gross Law Firm
Via AccessWire
Topics
Lawsuit

Via NewMediaWire
Topics
Lawsuit

LAWSUITS FILED AGAINST INNV, BMRN and FB - Jakubowitz Law Pursues Shareholders Claims
November 08, 2021
From Jakubowitz Law
Via AccessWire


The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BMRN, AMRN and RECAF
November 08, 2021
From The Gross Law Firm
Via AccessWire
Topics
Intellectual Property




LAWSUITS FILED AGAINST APPH, BMRN and RECAF - Jakubowitz Law Pursues Shareholders Claims
November 05, 2021
From Jakubowitz Law
Via AccessWire

Via NewMediaWire
Topics
Lawsuit


Via NewMediaWire
Topics
Lawsuit




Via NewMediaWire
Topics
Lawsuit

LAWSUITS FILED AGAINST BMRN, AMRN and CEI - Jakubowitz Law Pursues Shareholders Claims
November 03, 2021
From Jakubowitz Law
Via AccessWire





The Gross Law Firm Announces Class Actions on Behalf of Shareholders of APPH, BMRN and AMRN
October 31, 2021
From The Gross Law Firm
Via AccessWire
Topics
Intellectual Property



The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAM, BMRN and AMRN
October 29, 2021
From The Gross Law Firm
Via AccessWire
Topics
Intellectual Property

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HYZN, INNV and BMRN
October 28, 2021
From The Gross Law Firm
Via AccessWire
Topics
Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HYZN, BMRN and AMRN
October 28, 2021
From The Gross Law Firm
Via AccessWire
Topics
Intellectual Property

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.